重新评估多价 GlcNAc 末端寡糖对免疫反应的调节作用中 NK 细胞和 C 型凝集素样 NK 受体的参与。
Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
机构信息
Institute of Microbiology, ASCR v.v.i., Department of Immunology and Gnotobiology, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
出版信息
Immunol Lett. 2013 Nov-Dec;156(1-2):110-7. doi: 10.1016/j.imlet.2013.09.009. Epub 2013 Sep 25.
Recognition of glycosylation patterns is one of the basic features of innate immunity. Ability of C-type lectin-like receptors such as NKR-P1 to bind saccharide moieties has become recently a controversial issue. In the present study, binding assay with soluble fluorescently labeled recombinant rat NKR-P1A and mouse NKR-P1C proteins revealed apparently no affinity to the various neoglycoproteins. Lack of functional linkage between NKR-P1 and previously described saccharide binder was supported by the fact, that synthetic N-acetyl-D-glucosamine octabranched dendrimer on polyamidoamine scaffold (GN8P) did not change gene expression of NKR-P1 isoforms in C57BL/6 and BALB/c mice divergent in the NK gene complex (both in vitro and in vivo). Surprisingly, N-acetyl-D-glucosamine-coated tetrabranched polyamido-amine dendrimer specifically binds to NKT cells and macrophages but not to NK cells (consistently with changes in cytokine patterns). Despite the fact that GN8P has been tested as an immunomodulator in anti-cancer treatment animal models for many years, surprisingly no changes in cytokine profiles in serum relevant to anti-cancer responses using B16F10 and CT26 harboring mouse strains C57BL/6 and BALB/c are observed. Our results indicate possible indirect involvement of NK cells in GN8P mediated immune responses.
糖基化模式的识别是先天免疫的基本特征之一。C 型凝集素样受体(如 NKR-P1)结合糖基部分的能力最近成为一个有争议的问题。在本研究中,通过可溶性荧光标记的重组大鼠 NKR-P1A 和小鼠 NKR-P1C 蛋白的结合测定,显然没有与各种糖基化蛋白结合的亲和力。NKR-P1 与先前描述的糖结合物之间缺乏功能联系,这一事实得到了支持,即多聚酰胺支架上的 N-乙酰-D-葡萄糖胺八臂树枝状大分子(GN8P)不会改变在 NK 基因复合物中存在差异的 C57BL/6 和 BALB/c 小鼠中 NKR-P1 同工型的基因表达(无论是在体外还是体内)。令人惊讶的是,N-乙酰-D-葡萄糖胺包被的四臂聚酰胺胺树枝状大分子特异性地结合 NKT 细胞和巨噬细胞,但不结合 NK 细胞(与细胞因子模式的变化一致)。尽管 GN8P 多年来一直作为癌症治疗动物模型中的免疫调节剂进行测试,但令人惊讶的是,在使用 C57BL/6 和 BALB/c 小鼠品系携带的 B16F10 和 CT26 进行的与抗癌反应相关的血清细胞因子谱中没有观察到变化。我们的结果表明,NK 细胞可能间接参与了 GN8P 介导的免疫反应。